| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chairman | Executive Chairman +1 more
2 companies
El-Hibri Fuad is a Director at Emergent BioSolutions Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 6 buys and 9 sells.
Estimated insider holdings value: $25.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2019 | APVO Aptevo Therapeutics Inc. | Board Of Directors | Buy | 26,460 | $0.90 | $23,739.91 | +2.9% | |
| Jul 18, 2019 | APVO Aptevo Therapeutics Inc. | Board Of Directors | Buy | 14,404 | $0.87 | $12,596.30 | +1.6% | |
| Jul 17, 2019 | APVO Aptevo Therapeutics Inc. | Board Of Directors | Buy | 19,136 | $0.87 | $16,703.81 | +2.2% | |
| Jul 16, 2019 | APVO Aptevo Therapeutics Inc. | Board Of Directors | Buy | 11,375 | $0.85 | $9,661.93 | +1.3% | |
| Jul 11, 2019 | APVO Aptevo Therapeutics Inc. | Board Of Directors | Buy | 14,691 | $0.85 | $12,453.56 | +1.7% | |
| Jul 10, 2019 | APVO Aptevo Therapeutics Inc. | Director | Buy | 18,919 | $0.85 | $16,058.45 | +2.3% | |
| Feb 28, 2019 | EBS Emergent Biosolutions Inc. | Chairman | Sale+OE | 27,725 | $58.83 | $1,630,931.30 | -0.6% | |
| Nov 27, 2018 | EBS Emergent Biosolutions Inc. | Chairman | Sell | 45,832 | $69.79 | $3,198,698.88 | -1.6% | |
| Nov 20, 2018 | EBS Emergent Biosolutions Inc. | Chairman | Sell | 35,173 | $69.75 | $2,453,365.19 | -1.2% | |
| Aug 14, 2018 | EBS Emergent Biosolutions Inc. | Chairman | Sell | 36,318 | $55.98 | $2,033,109.26 | -1.2% |